Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Pharmacogenet Genomics. 2013 Dec;23(12):706–716. doi: 10.1097/FPC.0000000000000011

Table 5.

Variables predicting ad libitum D0-nicotine glucuronidationa in a multivariate regression model in current smokers

Variable nb Parameter estimate p
CYP2A6 normal allelesc 88 −0.009 ± 0.003 0.003
CYP2A6*1A 16 −0.007 ± 0.003 0.02
CYP2A6*9 6 −0.007 ± 0.004 0.09
UGT2B10*2 (67Y) 11 −0.007 ± 0.002 0.0007
UGT2B10*3 (481D) 2 0.012 ± 0.005 0.02
Total adjusted R2 0.37

Results of linear regression analyses treating CYP2A6 null alleles (CYP2A6*2, *4, *12 and *38) and UGT2B10*1 as the reference. Genetic variables are coded as number of haplotypes per subject (0,1,2). Negative parameter estimates indicate reduced nicotine glucuronidation relative to the reference genotype.

a

Non-deuterated (D0)-(nicotine-glucuronide / (nicotine-glucuronide + nicotine + cotinine + cotinine-glucuronide + trans-3′-hydroxycotinine))

b

number of alleles

c

all CYP2A6 alleles excluding CYP2A6*1A, *9 and assumed null alleles CYP2A6*2, *4, *12 and *38.